Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Dietary supplements continues to expand in 2023 as consumers have a large variety of products to choose from and are responding favourably to new product launches. At the end of 2022, for instance, Megalabs, launched InvitaEnergy, a combination of…
Probiotic supplements is a standout product within dietary supplements and is expected to register double-digit volume growth in 2023. Probiotics supplements are available over the counter, but part of their success is due to sales representatives…
Towards the end of the review period, direct seller Herbalife launched a new product called Immunity Essentials. This supplement can be mixed into water, tea or other drinks, and is taken once a day to support the functioning of the immune system. It…
Following the emergence of the pandemic in 2020 and into the following year, dietary supplements experienced robust growth, fuelled by consumers' desire to boost their immune systems and overall health. However, consumer interests shifted during…
Dietary supplements is enjoying healthy growth, with trends similar to those seen in vitamins. For example, products which offer multiple benefits are proving popular and, in this case, combination dietary supplements is showing the most robust…
For the second consecutive year, dietary supplements is expected to register a significant fall in volume sales. Two main factors are causing this negative performance. With concerns about COVID-19 abating, consumers are less concerned about boosting…
Retail sales of digestive remedies saw accelerated growth in constant value terms in 2023, as consumers returned to their busy, pre-pandemic lifestyles. With fears over the COVID-19 pandemic beginning to subside, there was notable increase in the…
The increased availability of low-cost generic proton pump inhibitors containing compounds such as omeprazole are dampening volume sales of antacids. Despite omeprazole being registered as an Rx drug, it is widely available, and can be accessed…
Digestive remedies is set to show double-digit growth in current value terms in Brazil in 2023; a result primarily driven by antacids and diarrhoeal remedies. Together, these two categories account for more than half of value sales of digestive…
Digestive remedies in Chile is experiencing a deceleration in value growth during 2023 compared to the double-digit increases observed in the previous two years. Despite a general decline in demand, the category continues to show healthy growth rates…